This article goes into the clinical recommendations for these patients.
Refresh me on what’s happening with CyPass?
Alcon recently pulled the CyPass microstent off the market after results from a five year study showed significant endothelial cell loss in the CyPass patients as compared to the patients who underwent cataract surgery alone.
